Cited by 571Cancer Genomics and DiagnosticsCancer Cells and MetastasisLung Cancer Treatments and Mutations

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

Precision medicine for cancer with next-generation functional diagnostics

Open access

Friedman, Adam A., Letai, Anthony, Fisher, David E., Flaherty, Keith T.·2015·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Precision medicine is about matching the right drugs to the right patients. Although this approach is technology agnostic, in cancer there is a tendency to make precision medicine synonymous with genomics. However, genome-based cancer therapeutic matching is limited by incomplete biological understanding of the relationship between phenotype and cancer genotype. This limitation can be addressed by functional testing of live patient tumour cells exposed to potential therapies. Recently, several 'next-generation' functional diagnostic technologies have been reported, including novel methods for tumour manipulation, molecularly precise assays of tumour responses and device-based in situ approaches; these address the limitations of the older generation of chemosensitivity tests. The promise of these new technologies suggests a future diagnostic strategy that integrates functional testing with next-generation sequencing and immunoprofiling to precisely match combination therapies to individual cancer patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc4015

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Self-citation
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753

Flagged first, then by citations

Show all 108 references

Sorted by citations

Items 301–400 of 571

Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo
Xande, J. G., Dias, A. P., Tamura, R. E., Cruz, M. C., Brito, B., Ferreira, R. A., Strauss, B. E., & Costanzi-Strauss, E. (2019) · Gene Therapy · doi:10.1038/s41434-019-0096-1 · Cited by 14
A tool for browsing the Cancer Dependency Map reveals functional connections between genes and helps predict the efficacy and selectivity of candidate cancer drugsPreprint
Shimada, K., Muhlich, J. L., & Mitchison, T. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.13.874776 · Cited by 14
Precision head and neck surgery: robotics and surgical vision technology
Holsinger, F. C., Birkeland, A. C., & Topf, M. C. (2021) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000706 · Cited by 13
Big data in breast cancer: Towards precision treatment
Zhang, H., Hussin, H., Hoh, C.-C., Cheong, S.-H., Lee, W.-K., & Yahaya, B. H. (2024) · Digital Health · doi:10.1177/20552076241293695 · Cited by 13
Conditional cell reprogramming for modeling host‐virus interactions and human viral diseases
Liu, X., & Mondal, A. M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26093 · Cited by 13
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy
Manzano-Muñoz, A., Yeste, J., Ortega, M. A., Martín, F., López, A., Rosell, J., Castro, S., Serrano, C., Samitier, J., Ramón‐Azcón, J., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00333-0 · Cited by 14
A TOP2A‑derived cancer panel drives cancer progression in papillary renal cell carcinoma
Ye, M., He, Z., Dai, W., Li, Z., Chen, X., & Liu, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9179 · Cited by 13
A Simple Three-dimensional Hydrogel Platform Enables Ex Vivo Cell Culture of Patient and PDX Tumors for Assaying Their Response to Clinically Relevant Therapies
Hribar, K. C., Wheeler, C. J., Bazarov, A. V., Varshneya, K., Yamada, R., Buckley, P., & Patil, C. G. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0359 · Cited by 13
Translational Potential of Neuroimaging Genomic Analyses to Diagnosis and Treatment in Mental Disorders
Chen, J., Liu, J., & Calhoun, V. D. (2019) · Proceedings of the IEEE · doi:10.1109/jproc.2019.2913145 · Cited by 13
Towards the Delivery of Precision Veterinary Cancer Medicine
Katogiritis, A., & Khanna, C. (2019) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2019.04.011 · Cited by 13
Major challenges in accurate mutation detection of multifocal lung adenocarcinoma by next-generation sequencing
Qiu, T., Li, W., Zhang, F., Wang, B., & Ying, J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1674070 · Cited by 13
A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report
Huang, Y., Xu, J., Li, K., Wang, J., Dai, Y., & Kang, Y. (2021) · Cancer Management and Research · doi:10.2147/cmar.s276799 · Cited by 13
Autonomous All-in-One Patch for Closed-Loop Diagnosis–Therapy of Melanoma
Guo, L., Zhang, F., Wang, L., Zhou, G., Zheng, Y., Ren, L., Wang, Z., Yin, J., Wu, W., & Yuan, M. (2025) · ACS Sensors · doi:10.1021/acssensors.5c00791 · Cited by 12
Is Personalized Medicine Here?
Carneiro, B. A., Costa, R. L. B., Taxter, T., Chandra, S., Chae, Y. K., Cristofanilli, M., & Giles, F. J. (2016) · PubMed · Cited by 12
Unveiling Pharmacogenomics Insights into Circular RNAs: Toward Precision Medicine in Cancer Therapy
Alqahtani, S., Alqahtani, T., Venkatesan, K., Sivadasan, D., Ahmed, R., Elfadil, H., Paulsamy, P., & Periannan, K. (2025) · Biomolecules · doi:10.3390/biom15040535 · Cited by 12
AI-driven dynamic grouping for adaptive clinical trials: Rethinking randomization in precision medicine
Mangalam, M. (2025) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2025.103272 · Cited by 12
64Cu/177Lu-DOTA-diZD, a Small-Molecule-Based Theranostic Pair for Triple-Negative Breast Cancer
Huang, Y., Yang, Z., Li, F., Zhao, H., Li, C., Yu, N., Hamilton, D. J., & Li, Z. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01957 · Cited by 12
Detergents: Friends not foes for high‐performance membrane proteomics toward precision medicine
Zhang, X. (2016) · PROTEOMICS · doi:10.1002/pmic.201600209 · Cited by 14
Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy
Gál, B., Veselý, M., Čolláková, J., Nekulová, M., Jůzová, V., Chmelík, R., & Veselý, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183399 · Cited by 12
Precision medicine for multiple sclerosis promotes preventative medicine
Hansen, M. R., & Okuda, D. T. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13846 · Cited by 12
FRL: An Integrative Feature Selection Algorithm Based on the Fisher Score, Recursive Feature Elimination, and Logistic Regression to Identify Potential Genomic Biomarkers
Ge, C., Luo, L., Zhang, J., Meng, X., & Chen, Y. (2021) · BioMed Research International · doi:10.1155/2021/4312850 · Cited by 12
Natural bioactive molecules and chemotherapeutics synergism for enhanced cancer therapy
Hashemi, M., Heshmatzad, K., Shahsavan, G., Tavakolpour, V., Esfahani, S. K., Karimi, P., Beikzadeh, N., Mashhadikhan, S., Nasirzade, S., Farahani, A. V., et al. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01094-4 · Cited by 11
Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer
Bai, Y., Lü, Z., Zhang, C., Guo, M., Xia, L., Tang, Z., Liu, Y., & Deng, S. (2023) · Oncogene · doi:10.1038/s41388-023-02866-5 · Cited by 12
Delineating functional and molecular impact of ex vivo sample handling in precision medicine
Struyf, N., Österroos, A., Vesterlund, M., Arnroth, C., James, T., Sunandar, S., Mermelekas, G., Bohlin, A., Levedahl, K. H., Bengtzén, S., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00528-7 · Cited by 11
Zebrafish patient-derived xenograft system for predicting carboplatin resistance and metastasis of ovarian cancer
Song, F., Yi, X., Zheng, X., Zhang, Z., Zhao, L., Shen, Y., Ye, Z., Liu, T., Liu, X., Xu, T., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101162 · Cited by 11
Trends in Precision Medicine
Kaur, J., Rahat, B., Thakur, S., & Kaur, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809411-2.00015-5 · Cited by 14
Artificial Intelligence Approaches in Drug Discovery: Towards the Laboratory of the Future
Frusciante, L., Visibelli, A., Geminiani, M., Santucci, A., & Spiga, O. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666221006140825 · Cited by 11
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial
Ishimaru, S., Shimoi, T., Sunami, K., Nakajima, M., Ando, Y., Okita, N. T., Nakamura, K., Shibata, T., Fujiwara, Y., & Yamamoto, N. (2023) · International Journal of Clinical Oncology · doi:10.1007/s10147-023-02439-2 · Cited by 11
Pharmacometabolomics in Drug Disposition, Toxicity, and Precision Medicine
Trevor, G. R., Lim, Y. J., & Urquhart, B. L. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001074 · Cited by 11
Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches
Lee, H.-Y., Chen, Y., Li, C., Li, W., Hsu, Y.-L., Yeh, H., Ke, H., Huang, C., Li, C., Wu, W., et al. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.29560 · Cited by 11
Tumor microenvironment-activatable boolean logic supramolecular nanotheranostics based on a pillar[6]arene for tumor hypoxia imaging and multimodal synergistic therapy
Liu, X., Meng, C., Ji, G., Liu, J., Zhu, P. W., Qian, J., Zhu, S., Zhang, Y., & Ling, Y. (2021) · Materials Chemistry Frontiers · doi:10.1039/d1qm00411e · Cited by 11
Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
Panovska, D., & Smet, F. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158637 · Cited by 11
Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells
Grundy, M. A., Jones, T., Elmi, L., Hall, M., Graham, A., Russell, N. H., & Pallis, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196805 · Cited by 11
Afatinib treatment for her-2 amplified metastatic colorectal cancer based on patient-derived xenograft models and next generation sequencing
Yang, M., Fang, X., Li, J., Xu, D., Xiao, Q., Yu, S., Hu, H., Weng, S., Ding, K., & Yuan, Y. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1529120 · Cited by 11
Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer
Li, X., Song, C., Wang, K., Li, N., Sun, S., Li, N., Zhao, Z., & Li, M. (2019) · Cancer Biomarkers · doi:10.3233/cbm-182094 · Cited by 11
Panoptic View of Prognostic Models for Personalized Breast Cancer Management
Saini, G., Mittal, K., Rida, P. C. G., Janssen, E. A. M., Gogineni, K., & Aneja, R. (2019) · Cancers · doi:10.3390/cancers11091325 · Cited by 12
SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis.
Lin, Y., Zhong, W., Lin, Q., Ye, Y., Li, S., Chen, H., Liu, H., Xu, L., Zhuang, W., Chen, S., et al. (2023) · PubMed Central · Cited by 10
Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies
Rodríguez, J. V., Piñol, M., Sorolla, M. A., Parisi, E., Sorolla, A., Santacana, M., Ruiz, M., Parra, G., Aracil, M. B. B., Iglesias, M., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010024 · Cited by 10
Label-Free Detection of AR-V7 mRNA in Prostate Cancer Using Yb2Ti2O7–Based Electrolyte-Insulator-Semiconductor Biosensors
Weng, W., Han, J. C., Xie, H.-X., & Pan, T.-M. (2016) · Journal of The Electrochemical Society · doi:10.1149/2.1221614jes · Cited by 10
A personalized approach to acute myeloid leukemia therapy: current options
Illangeswaran, R. S. S., Das, S., Paul, D. Z., Mathews, V., & Balasubramanian, P. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s168267 · Cited by 10
Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
Liu, D., Hou, X., Wu, W., Zanfagnin, V., Li, Y., Correia, C., Zhao, Z., Zhao, C., Liu, Z., Zhang, T., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04073-0 · Cited by 10
Colorectal cancer tissue-originated spheroids reveal tumor intrinsic signaling pathways and mimic patient clinical chemotherapeutic response as a rapid and valid model
Zhang, Y., Huo, J., Yu, S., Feng, W., Tuersun, A., Chen, F., Lv, Z., Liu, W., Zhao, J., Xu, Z., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115585 · Cited by 10
Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine
Kannampuzha, S., Murali, R., Gopalakrishnan, A. V., Mukherjee, A. G., Wanjari, U. R., Namachivayam, A., George, A., Dey, A., & Vellingiri, B. (2023) · Medical Oncology · doi:10.1007/s12032-023-02168-6 · Cited by 11
The LMIT: Light-mediated minimally-invasive theranostics in oncology
Fan, Y., Liu, S., Gao, E., Guo, R., Dong, G., Li, Y., Gao, T., Tang, X., & Liao, H. (2023) · Theranostics · doi:10.7150/thno.87783 · Cited by 10
Nanotechnology in Hematology: Enhancing Therapeutic Efficacy With Nanoparticles
Fard, N. T., Khademi, M., Salahi‐Niri, A., & Esmaeili, S. (2025) · Health Science Reports · doi:10.1002/hsr2.70647 · Cited by 10
Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments
Talwelkar, S. S., Mäyränpää, M. I., Søraas, L., Potdar, S., Bao, J., Hemmes, A., Linnavirta, N., Lømo, J., Räsänen, J. V., Knuuttila, A., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100373 · Cited by 10
DNA‐Scaffolded Disulfide Redox Network for Programming Drug‐Delivery Kinetics
Ji, W., Li, X., Xiao, M., Sun, Y., Lai, W., Zhang, H., Pei, H., & Li, L. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202100149 · Cited by 10
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations
Friedman, A. A., Xia, Y. F., Trippa, L., Le, L. P., Igras, V., Frederick, D. T., Wargo, J. A., Tanabe, K. K., Lawrence, D. P., Neuberg, D. S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3029 · Cited by 11
Self-citation
Approaches to identify kinase dependencies in cancer signalling networks
Dermit, M., Dokal, A. D., & Cutillas, P. R. (2017) · FEBS Letters · doi:10.1002/1873-3468.12748 · Cited by 10
Comprehensive evaluation of computational cell-type quantification methods for immuno-oncologyPreprint
Sturm, G., Finotello, F., Petitprez, F., Zhang, J. D., Baumbach, J., Fridman, W. H., List, M., & Aneichyk, T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/463828 · Cited by 10
Computational Methods to Investigate the Impact of miRNAs on Pathways
Alaimo, S., Micale, G., Ferlita, A. L., Ferro, A., & Pulvirenti, A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9207-2_11 · Cited by 9
Digital governance in tax-funded European healthcare systems: from the Back office to patient empowerment
Mattei, P. (2020) · Israel Journal of Health Policy Research · doi:10.1186/s13584-020-0361-1 · Cited by 9
A novel NGS ‐based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients
Zhang, X., Fan, X., Sun, C., Wang, L., Miao, Y., Wang, L., Yang, P., Xu, Y., Ren, X., Wu, X., et al. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.306 · Cited by 9
Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment
Ngo, H. K. C., Le, H., & Surh, Y. (2023) · Journal of Cancer Prevention · doi:10.15430/jcp.2023.28.4.131 · Cited by 9
Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth
Teramae, F., Makino, T., Sengoku, S., Lim, Y., Natori, T., & Kodama, K. (2020) · Sustainability · doi:10.3390/su12218938 · Cited by 9
Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review
Kasi, A., Al‐Jumayli, M., Park, R., Baranda, J. C., & Sun, W. (2020) · Journal of Pancreatic Cancer · doi:10.1089/pancan.2020.0010 · Cited by 9
Precision Medicine in Myeloma: Challenges in Defining an Actionable Approach
González‐Calle, V., Keane, N., Braggio, E., & Fonseca, R. (2017) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2017.06.021 · Cited by 9
Whole-Transcriptome Sequencing: A Powerful Tool for Vascular Tissue Engineering and Endothelial Mechanobiology
Kutikhin, A. G., Sinitsky, M. Y., Yuzhalin, A. E., & Velikanova, E. A. (2018) · Microarrays · doi:10.3390/ht7010005 · Cited by 10
Screening Dys-Methylation Genes and Rules for Cancer Diagnosis by Using the Pan-Cancer Study
Zhang, Y., Zeng, T., Pan, X., Guo, W., Gan, Z., Zhang, Y., Huang, T., & Cai, Y. (2019) · IEEE Access · doi:10.1109/access.2019.2961402 · Cited by 9
Rapid, precise, and reliable measurement of delay discounting using a Bayesian learning algorithmPreprint
Ahn, W., Gu, H., Shen, Y. I., Haines, N., Hahn, H. A., Teater, J. E., Myung, J. I., & Pitt, M. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/567412 · Cited by 9
Translational Opportunities for Microfluidic Technologies to Enable Precision Epigenomics
Xu, Y. F., Doonan, S. R., Ördög, T., & Bailey, R. C. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01288 · Cited by 10
Genetic Testing and its Role in Precision Medicine: Understand Disease Risk and Tailoring Treatments
Islam, Z., Zainullah, Khan, A., Aslam, M., Khan, A. U., & Rehman, M. U. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i1.515 · Cited by 8
Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes
Trigos, A., Goudey, B., Bedő, J., Conway, T., Faux, N. G., & Wyres, K. L. (2021) · mSphere · doi:10.1128/msphere.00245-21 · Cited by 8
Novel Therapeutics for Advanced Differentiated Thyroid Cancer
Lieberman, L., & Worden, F. P. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.019 · Cited by 8
A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
Kimmerling, R. J., Stevens, M. M., Olçum, S., Minnah, A., Vacha, M., LaBella, R., Ferri, M., Wasserman, S. C., Fujii, J., Shaheen, Z., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04270-3 · Cited by 8
Evaluation of the prognostic significances of γ‑secretase genes in pancreatic cancer
Jeon, Y., Ha, M., Kim, S. H., Kim, M. K., Lee, C., Oh, C., Han, M., Oh, S., & Kim, Y. H. (2019) · Oncology Letters · doi:10.3892/ol.2019.10113 · Cited by 8
The role of PET in imaging of the tumour microenvironment and response to immunotherapy
Lilburn, D. M. L., & Groves, A. M. (2021) · Clinical Radiology · doi:10.1016/j.crad.2021.08.004 · Cited by 8
Moving the needle: Employing deep reinforcement learning to push the boundaries of coarse-grained vaccine models
Faris, J. G., Orbidan, D., Wells, C., Petersen, B. K., & Sprenger, K. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1029167 · Cited by 8
From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development
Doroshow, D. B., & Doroshow, J. H. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000386 · Cited by 9
In Silico Cell-Type Deconvolution Methods in Cancer Immunotherapy
Sturm, G., Finotello, F., & List, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0327-7_15 · Cited by 9
Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma
Liao, C., Yang, L., Lee, L., Lin, C., Wang, H., Ng, S., Yen, T., Fan, W., & Hsieh, C. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105547 · Cited by 8
Integrating functional genomics to accelerate mechanistic personalized medicinePreprint
Tyner, J. W. (2017) · Molecular Case Studies · doi:10.1101/mcs.a001370 · Cited by 10
Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology
Ziogas, D. E., Kyrochristos, I. D., & Roukos, D. H. (2017) · Expert Review of Medical Devices · doi:10.1080/17434440.2017.1419059 · Cited by 8
Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments
Chan, S. P. Y., Rashid, M. B. M. A., Lim, J. J., Goh, J. J. N., Wong, W. Y., Hooi, L., Ismail, N. N., Luo, B., Chen, B. J., Noor, N. F. B. M., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00851-7 · Cited by 7
Monitoring of circulating epithelial tumor cells using the Maintrac ® method and its potential benefit for the treatment of patients with colorectal cancer
Gold, M., Pachmann, K., Kiani, A., & Schobert, R. (2021) · Molecular and Clinical Oncology · doi:10.3892/mco.2021.2363 · Cited by 7
Global Genetics Research in Prostate Cancer: A Text Mining and Computational Network Theory Approach
Azam, M. F., Musa, A., Dehmer, M., Yli-Harja, O. P., & Emmert‐Streib, F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00070 · Cited by 7
Design, Synthesis and Biological Evaluation of Novel 5‐Phenyl‐5‐(thiophen‐2‐yl)‐4 H ‐1,2,4‐triazole‐3‐thiols as an Anticancer Agent
Patel, K. R., Brahmbhatt, J., Pandya, P. A., Bhadresha, K. P., Daraji, D. G., Patel, H. D., Rawal, R., Baran, S. K., & Jayanthi, S. (2021) · ChemistrySelect · doi:10.1002/slct.202100025 · Cited by 7
Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks
Schneider, D. J., Riegman, P. H. J., Cronin, M., Negrouk, A., Moch, H., Balling, R., Penault-Llorca, F. M., Zatloukal, K., & Horgan, D. (2016) · Public Health Genomics · doi:10.1159/000446534 · Cited by 7
A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma
Lim, K., Langley, E. J., Gao, F., Luo, J. R., Li, L., Meyer, G. E., Kim, P., Singh, S., Kushnir, V. M., Early, D. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15653 · Cited by 7
Epilepsy: Advances in genetics and pathophysiology
Mantegazza, M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.10.026 · Cited by 7
Multiparameter cell characterization using nanofluidic technology facilitates real-time phenotypic and genotypic elucidation of intratumor heterogeneityPreprint
Beaumont, K. G., Hamou, W., Bozinovic, N., Silvers, T. R., Shah, H., Dave, A., Allette, K., Strahl, M., Wang, Y., Arib, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/457010 · Cited by 7
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
Cruz, F. S. D., Stewart, E. A., Surdez, D., Daley, J. D., Soragni, A., Tomazou, E. M., Alvarez-Perez, J., Feinberg, T. Y., Amatruda, J. F., Ganapathi, S. S., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-25-0428 · Cited by 6
Patient-derived melanoma models
Karras, F., & Kunz, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155231 · Cited by 6
Personalization of the medical treatment of solid tumours using patient-derived tumour explants (Review)
Louandre, C., Donnadieu, J., Lachaier, E., Page, C., Chauffert, B., & Galmiche, A. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3345 · Cited by 6
Progress towards precision functional genomics in cancer
Johannessen, C. M., & Boehm, J. S. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.02.002 · Cited by 6
A first glance on the enhancement of digital cell activity videos from glioblastoma cells with nuclear staining
Calderon, S., Moya, D., Cruz, J. C., & Valverde, J. M. (2016) · IEEE Central America and Panama Convention (CONCAPAN) · doi:10.1109/concapan.2016.7942344 · Cited by 6
Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?
Fernandes, G. D. S., Marques, D. F., Girardi, D. M., Braghiroli, M. I., Coudry, R. A., Meireles, S. I., Katz, A., & Hoff, P. M. (2017) · Clinics · doi:10.6061/clinics/2017(10)01 · Cited by 6
Pharmacological approaches to understanding protein kinase signaling networks
Stephenson, E. H., & Higgins, J. M. G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1310135 · Cited by 6
A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer
Penson, R. T., Sales, E., Sullivan, L., Borger, D. R., Krasner, C. N., Goodman, A., del Carmen, M. G., Growdon, W. B., Schorge, J. O., Boruta, D. M., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.02.032 · Cited by 6
A microchip for integrated single-cell genotoxicity assay
Dong, H., Sun, H. R., & Zheng, J. (2016) · Talanta · doi:10.1016/j.talanta.2016.09.040 · Cited by 6
Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation
Stulpinas, A., Imbrasaitė, A., Krestnikova, N., & Kalvelytė, A. V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89395 · Cited by 7
Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy
Alkhilaiwi, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761986 · Cited by 6
A Novel High-Throughput Multispectral Cell Segmentation Algorithm
Golbstein, J., Tocker, Y., Sharivkin, R., Tarcic, G., & Vidne, M. (2017) · Communications in computer and information science · doi:10.1007/978-3-319-60964-5_66 · Cited by 6
Integrated Analysis of Drug Sensitivity and Selectivity to Predict Synergistic Drug Combinations and Target Coaddictions in Cancer
Jaiswal, A., Yadav, B., Wennerberg, K., & Aittokallio, T. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8891-4_12 · Cited by 6
Evolution of oncosurgical management of pancreatic cancer
Klaiber, U., Roth, S., Hackert, T., & Neoptolemos, J. P. (2019) · European surgery. Supplement/European surgery · doi:10.1007/s10353-019-0587-8 · Cited by 6
Anticancer drug-induced nephrotoxicity: biopsy-proven patterns and outcomes across chemotherapy, targeted therapy, and immune checkpoint inhibitors
Tian, J., Lian, J., Xia, Y., Ma, L., Zhang, M., Zhu, X., Wang, G., Zhong, Y., & Zeng, C. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2590283 · Cited by 5
Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects
Aslani, S., & Saad, M. I. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3858-3_2 · Cited by 5
MGATAF: multi-channel graph attention network with adaptive fusion for cancer-drug response prediction
Saeed, D., Xing, H., AlBadani, B., Li, F., Al-Sabri, R., Abdullah, M., & Rehman, A. (2025) · BMC Bioinformatics · doi:10.1186/s12859-024-05987-0 · Cited by 5
A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design
Morfouace, M., Hewitt, S. M., Salgado, R., Hartmann, K., Litière, S., Tejpar, S., Golfinopoulos, V., Lively, T., Thurin, M., Conley, B. A., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.003 · Cited by 5
Theranostic nanosystem with supramolecular self-assembly for enhanced reactive oxygen species-mediated apoptosis guided by dual-modality tumor imaging
Yan, D., Zhang, H., Xu, X., Ren, C., Han, C., & Li, Z. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106241 · Cited by 5

Authors: Friedman, A. A., Letai, A., Fisher, D. E., & Flaherty, K. T.
Affiliations: Harvard University (US)
Corresponding author: Friedman, Adam A.
ORCID: Friedman, Adam A.
Letai, Anthony
Fisher, David E.
Flaherty, Keith T.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2015-11-05
Volume: 15
Issue: 12
Pages: 747-756
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc4015
PMC: PMC4970460
OpenAlex: W2176372762
Cited by: 570
References: 108
Citations by year: 2026: 19 · 2025: 43 · 2024: 26 · 2023: 42 · 2022: 41 · 2021: 67 · 2020: 93 · 2019: 63 · 2018: 59 · 2017: 73 · 2016: 43
FWCI: 5.69
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (UM1CA186709, P01CA066996)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
Keywords: precision oncology, functional diagnosis, chemosensitivity testing, genotype-phenotype correlation, next-generation sequencing, immune profiling, drug repurposing
MeSH terms: Humans, Neoplasms, Genomics, Molecular Diagnostic Techniques, Precision Medicine, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Precision medicine for cancer with next-generation functional diagnostics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks